Väljaminev kiriAvalik
Euroopa farmakopöa töökava asjus
Ravimiamet · 25. september 2024
- Viit
- REP-1/3446-2
- Registreeritud
- 25. september 2024
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2024
- Vastutaja
- Signe Leito (RA, Labor)
Sisu (failidest)
Survey for information on approved products containing anhydrous
ephedrine, ephedrine hemihydrate or ephedrine hydrochloride, racemic
page 1 / 5
Q1-3 (3566)
NPA: (47330)
Type: (!/list-dropdown)
A10 - Estonia (EE)
Is Ephedrine (0488, anhydrous base) used in approved products in your country?
(47331)
Type: (L/list-radio)
No
A3
page 2 / 5
Please list the names of any approved products in your country containing Ephedrine (0488)
and the contact details of any corresponding MAH(s) or information on substance
manufacturers. (47332)
Type: (T/text-long)
n.a
Is Ephedrine hemihydrate (0489) used in approved products in your country? (47336)
Type: (L/list-radio)
No
AO03
Please list the names of any approved products in your country containing Ephedrine
hemihydrate (0489) and the contact details of any corresponding MAH(s) or information on
substance manufacturers.
(47333)
Type: (T/text-long)
n.a
page 3 / 5
Is racemic Ephedrine hydrochloride (0715, anhydrous) used in approved products in your
country? (47337)
Type: (L/list-radio)
No
AO02
Please list the names of any approved products in your country containing Ephedrine
hydrochloride, racemic (0715) and the contact details of any corresponding MAH(s) or
information on substance manufacturers.
(47334)
Type: (T/text-long)
n.a
Comments:
(47335)
Type: (T/text-long)
-
page 4 / 5
page 5 / 5